Journal of medical Internet research
Conversational Agents for Asthma and Chronic Obstructive Pulmonary Disease Management: Scoping Review
By Hassan NB, Teo TP, Liew MF and 10 others.
Abstract
Background
Asthma and chronic obstructive pulmonary disease (COPD) affect more than 650 million people worldwide and remain leading causes of disability, with a rising burden as populations age. Conversational agents (CAs) may offer a more interactive alternative. However, the evidence in obstructive lung disease has not been mapped.
Objective
The aim of this study is to map the literature on CA use in asthma and COPD, to describe the roles they have been designed to perform, the outcomes that have been measured, and to map the study designs and methods characterizing the current evidence.
